Christiane Desel

Title: Christiane Desel: Innovator in Vaccine Development

Introduction

Christiane Desel is a prominent inventor based in Nuremberg, Germany. She has made significant contributions to the field of vaccine development, particularly in relation to mycobacterial diseases. With a total of two patents to her name, her work has the potential to impact public health significantly.

Latest Patents

Christiane Desel's latest patents include "Recombinant mycobacterium as a vaccine," which relates to a recombinant cell designed for use as a vaccine. Another notable patent is "Determination of the efficacy of an anti-mycobacterial vaccination," which focuses on methods and reagents for assessing the efficacy of vaccines, especially those targeting tuberculosis.

Career Highlights

Throughout her career, Christiane has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and Vakzine Projekt Management GmbH. Her experience in these institutions has allowed her to develop innovative solutions in vaccine research and development.

Collaborations

Some of her notable coworkers include Stefan H. E. Kaufmann and Silke Bandermann. Their collaborative efforts have contributed to advancements in the understanding and treatment of mycobacterial infections.

Conclusion

Christiane Desel's work in vaccine innovation showcases her dedication to improving health outcomes through scientific research. Her patents and collaborations highlight her significant role in the ongoing fight against infectious diseases.